609 related articles for article (PubMed ID: 9360057)
1. Metronidazole. A therapeutic review and update.
Freeman CD; Klutman NE; Lamp KC
Drugs; 1997 Nov; 54(5):679-708. PubMed ID: 9360057
[TBL] [Abstract][Full Text] [Related]
2. Metronidazole: in vitro activity, pharmacology and efficacy in anaerobic bacterial infections.
Tally FP; Sullivan CE
Pharmacotherapy; 1981; 1(1):28-38. PubMed ID: 6927601
[TBL] [Abstract][Full Text] [Related]
3. Metronidazole is still the drug of choice for treatment of anaerobic infections.
Löfmark S; Edlund C; Nord CE
Clin Infect Dis; 2010 Jan; 50 Suppl 1():S16-23. PubMed ID: 20067388
[TBL] [Abstract][Full Text] [Related]
4. Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases).
Pal D; Banerjee S; Cui J; Schwartz A; Ghosh SK; Samuelson J
Antimicrob Agents Chemother; 2009 Feb; 53(2):458-64. PubMed ID: 19015349
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
Lamp KC; Freeman CD; Klutman NE; Lacy MK
Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species.
Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC
Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431
[TBL] [Abstract][Full Text] [Related]
7. Symposium on antimicrobial agents. Metronidazole.
Rosenblatt JE; Edson RS
Mayo Clin Proc; 1987 Nov; 62(11):1013-7. PubMed ID: 3312851
[TBL] [Abstract][Full Text] [Related]
8. Metronidazole.
Rosenblatt JE; Edson RS
Mayo Clin Proc; 1983 Mar; 58(3):154-7. PubMed ID: 6600804
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of clinically isolated anaerobic bacteria in a University Hospital Centre Split, Croatia in 2013.
Novak A; Rubic Z; Dogas V; Goic-Barisic I; Radic M; Tonkic M
Anaerobe; 2015 Feb; 31():31-6. PubMed ID: 25479237
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
[TBL] [Abstract][Full Text] [Related]
11. Metronidazole: utilization in the obstetric and gynecologic patient.
Schwebke JR
Sex Transm Dis; 1995; 22(6):370-6. PubMed ID: 8578410
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
Shore KP; Pottumarthy S; Morris AJ
N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
[TBL] [Abstract][Full Text] [Related]
13. Low antibiotic resistance among anaerobic Gram-negative bacteria in periodontitis 5 years following metronidazole therapy.
Dahlen G; Preus HR
Anaerobe; 2017 Feb; 43():94-98. PubMed ID: 27988390
[TBL] [Abstract][Full Text] [Related]
14. Activity of fleroxacin alone and in combination with clindamycin or metronidazole in experimental intra-abdominal abscesses.
Pefanis A; Thauvin-Eliopoulos C; Holden J; Eliopoulos GM; Ferraro MJ; Moellering RC
Antimicrob Agents Chemother; 1994 Feb; 38(2):252-5. PubMed ID: 8192453
[TBL] [Abstract][Full Text] [Related]
15. Cephalosporin-metronidazole combinations in the management of intra-abdominal infections.
Nicolau DP; Patel KB; Quintiliani R; Nightingale CH
Diagn Microbiol Infect Dis; 1995; 22(1-2):189-94. PubMed ID: 7587038
[TBL] [Abstract][Full Text] [Related]
16. Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1978 Nov; 16(5):387-417. PubMed ID: 363399
[TBL] [Abstract][Full Text] [Related]
17. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
Seña AC; Bachmann LH; Hobbs MM
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole.
Hager WD; Rapp RP
Obstet Gynecol Clin North Am; 1992 Sep; 19(3):497-510. PubMed ID: 1436927
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of azlocillin, metronidazole and its hydroxy metabolite against anaerobes. Bacteriostatic synergism studies.
Werner H; Schädler G; Krasemann C
Arzneimittelforschung; 1983; 33(4):574-7. PubMed ID: 6683537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
